New Issue: Science’s Impossible Questions. Read Now

Parkinson's Treatment Linked to Compulsive Gambling

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Researchers have identified a strange side effect to a treatment for Parkinson's disease: excessive gambling. Some patients taking medications known as dopamine agonists developed the problem within three months of starting treatment, even though they had previously gambled only occasionally or never at all. "This is a striking effect," remarks J. Eric Ahlskog of the Mayo Clinic, a co-author of the new study. "Pathological gambling induced by a drug is really quite unusual."

Ahlskog and his colleagues identified gambling problems during routine clinic visits for 11 patients who suffer from Parkinson's disease, a degenerative disorder in which neurons in the brain region called the substantia nigra slowly die off. The neurotransmitter dopamine helps regulate movement and balance. In addition, it is active in the brain's reward system and helps mediate the rewards brought on by gambling. All of the patients in the new study were using dopamine agonists, compounds that mimic the behavior of the neurotransmitter in the brain, as part of their treatment regimes. In addition, eight of the patients were also taking the medication carbidopa/levodopa, which is a standard therapy for Parkinson's that replenishes dopamine levels in the brain. The researchers report in the current issue of the Archives of Neurology that their newly-developed gambling problems cost patients upwards of $100,000 and, in the case of one patient, led to the break-up of her marriage.

The scientists report that the good news is that only a small number of patients exhibit the compulsive gambling side effect. In addition, it is reversible and thus poses no reason to avoid these therapies, they say. When the patients tapered off use of the troubling medications, the desire to gamble compulsively also disappeared. "I'd want patients to be very forthcoming with their doctors about their gambling," says study co-author M. Leann Dodd. "If you recognize this association early, you can possibly prevent financial ruin or destruction of relationships."

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe